Vanda Pharmaceuticals Shares Outstanding 2006-2019 | VNDA

Vanda Pharmaceuticals shares outstanding from 2006 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Vanda Pharmaceuticals Annual Shares Outstanding
(Millions of Shares)
2018 53
2017 45
2016 43
2015 42
2014 37
2013 30
2012 28
2011 28
2010 29
2009 27
2008 27
2007 26
2006 16
2005 0
Vanda Pharmaceuticals Quarterly Shares Outstanding
(Millions of Shares)
Q3 2019 55
Q2 2019 55
Q1 2019 53
Q4 2018 53
Q3 2018 55
Q2 2018 54
Q1 2018 48
Q4 2017 45
Q3 2017 45
Q2 2017 45
Q1 2017 44
Q4 2016 43
Q3 2016 44
Q2 2016 43
Q1 2016 43
Q4 2015 42
Q3 2015 42
Q2 2015 42
Q1 2015 42
Q4 2014 37
Q3 2014 34
Q2 2014 34
Q1 2014 34
Q4 2013 33
Q3 2013 31
Q2 2013 28
Q1 2013 28
Q4 2012 28
Q3 2012 28
Q2 2012 28
Q1 2012 28
Q4 2011 28
Q3 2011 28
Q2 2011 28
Q1 2011 29
Q4 2010 29
Q3 2010 28
Q2 2010 28
Q1 2010 28
Q4 2009 27
Q3 2009 27
Q2 2009 27
Q1 2009 27
Q4 2008 27
Q3 2008 27
Q2 2008 27
Q1 2008 27
Q4 2007 26
Q3 2007 27
Q2 2007 27
Q1 2007 25
Q4 2006 16
Q3 2006 22
Q2 2006 19
Q1 2006 0
Q4 2005 0
Q3 2005 0
Q2 2005 0
Q1 2005 0
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.824B $0.193B
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of clinical-stage product candidates for central nervous system disorders. It is developing important new medicines to improve the lives of patients. It uses new technologies, including genetics & genomics, to inform our drug discovery, our clinical trials, and our commercial positioning of our compounds. The Company has three product candidates in clinical development. It's lead product candidate, iloperidone, is a compound for the treatment of schizophrenia & bipolar disorder & is in a Phase III clinical trial for schizophrenia. It's second product candidate, is a compound for the treatment of insomnia & depression which is currently in a Phase III clinical trial for insomnia. It's third product candidate, is a compound for the treatment of excessive sleepiness & is ready for a Phase II clinical trial.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $131.231B 15.12
CSL (CSLLY) Australia $84.984B 0.00
Gilead Sciences (GILD) United States $82.323B 10.20
Celgene (CELG) United States $78.303B 11.18
Vertex Pharmaceuticals (VRTX) United States $53.950B 55.07
Biogen (BIIB) United States $50.933B 8.74
Illumina (ILMN) United States $44.980B 49.35
Regeneron Pharmaceuticals (REGN) United States $37.865B 16.58
Alexion Pharmaceuticals (ALXN) United States $23.981B 11.84
Seattle Genetics (SGEN) United States $19.667B 0.00
Incyte (INCY) United States $18.675B 43.35
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.631B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.479B 0.00
Genmab (GNMSF) Denmark $13.448B 59.40
Exact Sciences (EXAS) United States $10.653B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.393B 49.88
Alnylam Pharmaceuticals (ALNY) United States $10.263B 0.00
Galapagos (GLPG) Belgium $10.073B 25.95
BeiGene (BGNE) Cayman Islands $9.413B 0.00
QIAGEN (QGEN) Netherlands $9.147B 29.82
Amarin (AMRN) Ireland $8.580B 0.00
Bio-Techne Corp (TECH) United States $8.097B 54.20
Guardant Health (GH) United States $7.513B 0.00
Sarepta Therapeutics (SRPT) United States $7.265B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.101B 0.00
Moderna (MRNA) United States $6.455B 0.00
Reata Pharmaceuticals (RETA) United States $5.988B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.668B 14.41
ARGENX SE-ADR (ARGX) Netherlands $5.311B 0.00
Exelixis (EXEL) United States $5.017B 14.11
Ascendis Pharma (ASND) Denmark $4.741B 0.00
China Biologic Products (CBPO) China $4.605B 25.94
Repligen (RGEN) United States $4.408B 79.88
Spark Therapeutics (ONCE) United States $4.269B 0.00
Bluebird Bio (BLUE) United States $4.149B 0.00
Medicines (MDCO) United States $4.144B 0.00
Mirati Therapeutics (MRTX) United States $3.784B 0.00
Blueprint Medicines (BPMC) United States $3.707B 0.00
Adaptive Biotechnologies (ADPT) United States $3.545B 0.00
Immunomedics (IMMU) United States $3.391B 0.00
Alkermes (ALKS) Ireland $3.308B 0.00
MorphoSys AG (MOR) Germany $3.299B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.139B 0.00
Genmab (GMAB) Denmark $2.876B 5.93
Emergent Biosolutions (EBS) United States $2.830B 28.11
Halozyme Therapeutics (HALO) United States $2.771B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.692B 0.00
MyoKardia (MYOK) United States $2.540B 0.00
NeoGenomics (NEO) United States $2.513B 133.72
Amicus Therapeutics (FOLD) United States $2.440B 0.00
UniQure (QURE) Netherlands $2.306B 0.00
Arena Pharmaceuticals (ARNA) United States $2.295B 5.34
Zai Lab (ZLAB) China $2.262B 0.00
RA PHARMCTL INC (RARX) United States $2.204B 0.00
Acceleron Pharma (XLRN) United States $2.175B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.084B 0.00
Cambrex (CBM) United States $2.018B 0.00
Ligand Pharmaceuticals (LGND) United States $1.893B 36.42
Myriad Genetics (MYGN) United States $1.840B 27.19
Akcea Therapeutics (AKCA) United States $1.813B 0.00
Insmed (INSM) United States $1.812B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.586B 0.00
Denali Therapeutics (DNLI) United States $1.454B 0.00
Zymeworks (ZYME) Canada $1.423B 0.00
Epizyme (EPZM) United States $1.399B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.394B 0.00
REGENXBIO (RGNX) United States $1.368B 0.00
Coherus BioSciences (CHRS) United States $1.330B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.321B 0.00
Innoviva (INVA) United States $1.260B 3.71
Zealand Pharma (ZLDPF) Denmark $1.185B 0.00
Editas Medicine (EDIT) United States $1.173B 0.00
Fate Therapeutics (FATE) United States $1.111B 0.00
Alector (ALEC) United States $1.101B 0.00
Sangamo Therapeutics (SGMO) United States $1.091B 0.00
Arvinas (ARVN) United States $1.029B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.000B 0.00
Zealand Pharma (ZEAL) Denmark $0.997B 0.00
Principia Biopharma (PRNB) United States $0.985B 0.00
WAVE Life Sciences (WVE) Singapore $0.983B 0.00
Athenex (ATNX) United States $0.901B 0.00
Codexis (CDXS) United States $0.881B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.875B 0.00
Anika Therapeutics (ANIK) United States $0.856B 27.78
Cara Therapeutics (CARA) United States $0.847B 0.00
Vericel (VCEL) United States $0.834B 310.83
ZIOPHARM Oncology Inc (ZIOP) United States $0.806B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.791B 0.00
Pharming Group (PHGUF) Netherlands $0.753B 0.00
Heska (HSKA) United States $0.722B 184.44
Twist Bioscience (TWST) United States $0.719B 0.00
Revance Therapeutics (RVNC) United States $0.713B 0.00
DBV Technologies S.A (DBVT) France $0.701B 0.00
ANI Pharmaceuticals (ANIP) United States $0.674B 11.49
MiMedx (MDXG) United States $0.653B 0.00
Intellia Therapeutics (NTLA) United States $0.650B 0.00
Precision BioSciences (DTIL) United States $0.615B 0.00
Mesoblast (MESO) Australia $0.609B 0.00
Adverum Biotechnologies (ADVM) United States $0.605B 0.00
Cellectis S.A (CLLS) France $0.574B 0.00
GENFIT S.A (GNFT) France $0.568B 0.00
Retrophin (RTRX) United States $0.556B 0.00
UROGEN PHARMA (URGN) United States $0.555B 0.00
BioDelivery Sciences (BDSI) United States $0.551B 0.00
Agenus (AGEN) United States $0.511B 0.00
Kadmon Holdings (KDMN) United States $0.508B 0.00
Intra-Cellular Therapies (ITCI) United States $0.498B 0.00
Stemline Therapeutics (STML) United States $0.497B 0.00
Dynavax Technologies (DVAX) United States $0.489B 0.00
Cytokineticsorporated (CYTK) United States $0.483B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.479B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.473B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.473B 0.00
AC Immune SA (ACIU) Switzerland $0.470B 10.88
Sinovac Biotech (SVA) China $0.460B 0.00
PHARMA MAR SA (PHMMF) Spain $0.440B 0.00
Prothena (PRTA) Ireland $0.418B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.375B 2.60
Merus (MRUS) Netherlands $0.368B 0.00
Bellus Health (BLU) Canada $0.363B 0.00
Arcus Biosciences (RCUS) United States $0.351B 0.00
Cellular Biomedicine (CBMG) United States $0.350B 0.00
Clovis Oncology (CLVS) United States $0.350B 0.00
PDL BioPharma (PDLI) United States $0.343B 8.57
AMAG Pharmaceuticals (AMAG) United States $0.334B 0.00
Starpharma Holdings (SPHRY) Australia $0.318B 0.00
Puma Biotechnology (PBYI) United States $0.310B 0.00
Kindred Biosciences (KIN) United States $0.304B 0.00
AnaptysBio (ANAB) United States $0.301B 0.00
Avid Bioservices (CDMO) United States $0.294B 0.00
Protagonist Therapeutics (PTGX) United States $0.290B 0.00
Compugen (CGEN) Israel $0.289B 0.00
Pfenex (PFNX) United States $0.279B 0.00
Theratechnologies (THTX) Canada $0.276B 0.00
Seres Therapeutics (MCRB) United States $0.271B 0.00
Gritstone Oncology (GRTS) United States $0.263B 0.00
Geron (GERN) United States $0.262B 0.00
Cel-Sci (CVM) United States $0.259B 0.00
Sutro Biopharma (STRO) United States $0.249B 0.00
Biofrontera AG (BFRA) Germany $0.248B 370.07
MannKind (MNKD) United States $0.247B 0.00
ADMA Biologics Inc (ADMA) United States $0.246B 0.00
CytomX Therapeutics (CTMX) United States $0.244B 0.00
Kamada (KMDA) Israel $0.238B 6.96
Inovio Pharmaceuticals (INO) United States $0.235B 0.00
Albireo Pharma (ALBO) United States $0.231B 0.00
Scholar Rock Holding (SRRK) United States $0.227B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.227B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.227B 0.00
XOMA (XOMA) United States $0.221B 0.00
Athersys (ATHX) United States $0.218B 0.00
POXEL SA FRANCE (PXXLF) France $0.213B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.213B 0.00
OSMOTICA PHARM (OSMT) United States $0.212B 0.00
Syros Pharmaceuticals (SYRS) United States $0.212B 0.00
Sorrento Therapeutics (SRNE) United States $0.204B 0.00
Cue Biopharma (CUE) United States $0.202B 0.00
Spero Therapeutics (SPRO) United States $0.195B 0.00
ChromaDex (CDXC) United States $0.189B 0.00
Affimed (AFMD) Germany $0.188B 0.00
Exicure (XCUR) United States $0.188B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.188B 0.00
Palatin Technologies (PTN) United States $0.181B 4.95
Senesco Technologies (ELOX) United States $0.169B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.166B 0.00
Arsanis (XFOR) United States $0.163B 0.00
Dyadic (DYAI) United States $0.163B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.149B 0.00
CorMedix Inc (CRMD) United States $0.143B 0.00
Nicox SA (NICXF) France $0.141B 0.00
Enzo Biochem (ENZ) United States $0.138B 0.00
Alcobra (ARCT) United States $0.135B 0.00
Northwest Biotherapeutics (NWBO) United States $0.133B 0.00
Cerecor (CERC) United States $0.132B 0.00
Mersana Therapeutics (MRSN) United States $0.131B 0.00
BioTime (LCTX) United States $0.130B 6.69
Emmaus Life Sciences (EMMA) United States $0.129B 0.00
Ophthotech (ISEE) United States $0.128B 0.00
Five Prime Therapeutics (FPRX) United States $0.128B 0.00
Fortress Biotech (FBIO) United States $0.126B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.122B 0.00
SESEN BIO, INC (SESN) United States $0.120B 0.00
Abeona Therapeutics (ABEO) United States $0.119B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.117B 0.00
Windtree Therapeutics (WINT) United States $0.116B 0.00
Aptinyx (APTX) United States $0.112B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.112B 0.00
Novavax (NVAX) United States $0.109B 0.00
NantKwest (NK) United States $0.108B 0.00
OvaScience (MLND) United States $0.107B 0.00
VBI Vaccines (VBIV) United States $0.105B 0.00
Menlo Therapeutics (MNLO) United States $0.105B 0.00
PHASEBIO PHARMA (PHAS) United States $0.102B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.101B 0.00
Antibe Therapeutics (ATBPF) Canada $0.093B 0.00
Aduro Biotech (ADRO) United States $0.089B 0.00
Acorda Therapeutics (ACOR) United States $0.087B 0.00
Arbutus Biopharma (ABUS) Canada $0.086B 0.00
Celyad SA (CYAD) Belgium $0.086B 0.00
Adocia (ADOCY) France $0.086B 0.00
Strongbridge Biopharma (SBBP) United States $0.086B 2.29
VTv Therapeutics (VTVT) United States $0.085B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.080B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.078B 0.00
ARAVIVE, INC (ARAV) United States $0.076B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.076B 0.00
Vaccinex (VCNX) United States $0.074B 0.00
Prima BioMed (IMMP) Australia $0.070B 0.00
Checkpoint Therapeutics (CKPT) United States $0.068B 0.00
Synlogic (SYBX) United States $0.068B 0.00
Selecta Biosciences (SELB) United States $0.067B 0.00
Liquidia Technologies (LQDA) United States $0.067B 0.00
Verastem (VSTM) United States $0.067B 0.00
Trevena (TRVN) United States $0.067B 0.00
Catalyst Biosciences (CBIO) United States $0.064B 0.00
Idera Pharmaceuticals (IDRA) United States $0.061B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.060B 0.00
NewLink Genetics (NLNK) United States $0.057B 0.00
Organovo Holdings (ONVO) United States $0.057B 0.00
Orgenesis (ORGS) United States $0.055B 3.56
Proteostasis Therapeutics (PTI) United States $0.054B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.053B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.053B 0.00
China Health Industries Holdings (CHHE) China $0.052B 15.78
Pluristem Therapeutics (PSTI) Israel $0.051B 0.00
Applied Genetic Technologies (AGTC) United States $0.050B 0.00
Curis (CRIS) United States $0.048B 0.00
AquaBounty Technologies (AQB) United States $0.046B 0.00
AIT Therapeutics (XAIR) United States $0.043B 0.00
Vascular Biogenics (VBLT) Israel $0.043B 0.00
DiaMedica Therapeutics (DMAC) United States $0.042B 0.00
Clearside Biomedical (CLSD) United States $0.042B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.041B 0.00
AmpliPhi Biosciences (ARMP) United States $0.041B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.041B 0.00
Evogene (EVGN) Israel $0.039B 0.00
Stellar Biotechnologies (EDSA) Canada $0.038B 0.00
Celldex Therapeutics (CLDX) United States $0.037B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.032B 0.00
Oncobiologics (OTLK) United States $0.031B 0.00
VIVUS (VVUS) United States $0.030B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 9.97
Protalix BioTherapeutics (PLX) Israel $0.029B 0.00
Entera Bio (ENTX) Israel $0.028B 0.00
Caladrius Biosciences (CLBS) United States $0.028B 0.00
Celsion (CLSN) United States $0.028B 0.00
Aptevo Therapeutics (APVO) United States $0.028B 0.00
Bionano Genomics (BNGO) United States $0.028B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.026B 0.00
BioCardia (BCDA) United States $0.026B 0.00
Unum Therapeutics (UMRX) United States $0.024B 0.00
Alimera Sciences (ALIM) United States $0.024B 0.00
Apricus Biosciences (SEEL) United States $0.023B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.022B 0.00
Signal Genetics (MGEN) United States $0.021B 0.00
AEterna Zentaris (AEZS) United States $0.020B 0.00
Novogen (KZIA) Australia $0.020B 0.00
Soligenix (SNGX) United States $0.019B 0.00
CollPlant Holdings (CLGN) Israel $0.019B 0.00
Aytu Bioscience (AYTU) United States $0.017B 0.00
Pulmatrix (PULM) United States $0.015B 0.00
Prana Biotechnology (ATHE) Australia $0.015B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.014B 0.00
TOCAGEN INC (TOCA) United States $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.014B 0.00
VistaGen Therapeutics (VTGN) United States $0.013B 0.00
IMMURON (IMRN) Australia $0.013B 0.00
TrovaGene (TROV) United States $0.012B 0.00
Cesca Therapeutics (THMO) United States $0.011B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
Titan Pharmaceuticals (TTNP) United States $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Advaxis (ADXS) United States $0.007B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.007B 0.00
Cleveland BioLabs (CBLI) United States $0.006B 0.00
BioPharmX (BPMX) United States $0.004B 0.00
IBio (IBIO) United States $0.004B 0.00
Neuralstem (SNCA) United States $0.002B 0.00